ARTICLE | Clinical News
Prosigna Breast Cancer Prognostic Gene Signature Assay regulatory update
September 16, 2013 7:00 AM UTC
NanoString said FDA granted 510(k) clearance for Prosigna Breast Cancer Prognostic Gene Signature Assay for use as a prognostic indicator for distant recurrence-free survival at 10 years. The breast c...